Hepatic arterial changes following iodized oil chemoembolization of hepatocellular carcinoma: Incidence and technical consequence

Artery Research

Volumn 6, Issue 1, 2012, Pages 21-27

  Gaba, Ron C ^a   Brodsky, Tamara R ^b   Knuttinen, M Grace ^a   Omene, Benedictta O ^a   Owens, Charles A ^a   Bui, James T ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Chemoembolization; Hepatic artery; Hepatocellular carcinoma; Iodized oil

Indexed keywords

IODINATED POPPYSEED OIL;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; DRUG DELIVERY SYSTEM; FEMALE; HEPATIC ARTERY; HUMAN; INCIDENCE; LIVER ANGIOGRAPHY; LIVER CELL CARCINOMA; LIVER CIRCULATION; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 84857042261     PISSN: 18729312     EISSN: 18764401     Source Type: Journal    
DOI: 10.1016/j.artres.2011.08.002     Document Type: Article

References (25)

1. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002, 359:1734-1739.
2. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002, 35:1164-1171.
3. Breedis C., Young G. The blood supply of neoplasm of the liver. Am J Pathol 1954, 30:969-985.
4. Bruix J., Sherman M., Practice Guidelines Committee, American Association for the Study of Liver Diseases Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
5. Ramsey D.E., Kernagis L.Y., Soulen M.C., Geschwind J.H. Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2002, 13:S211-S221.
6. Lewandowski R.J., Mulcahy M.F., Kulik L.M., et al. Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. Radiology 2010, 255:955-965.
7. Charnsangavej C., Kirk I.R., Dubrow R.A., et al. Arterial complications from long-term hepatic artery chemoinfusion catheters: evaluation with CT. AJR Am J Roentgenol 1993, 160:859-864.
8. Sueyoshi E., Hayashida T., Sakamoto I., Uetani M. Vascular complications of hepatic artery after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. AJR Am J Roentenol 2010, 195:245-251.
9. Belli L., Magistretti G., Puricelli G.P., Damiani G., Colombo E., Cornalba G.P. Arteritis following intra-arterial chemotherapy for liver tumors. Eur Radiol 1997, 7:323-326.
10. Geschwind J.H., Ramsey D.E., Cleffken B., et al. Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency. Cardiovasc Intervent Radiol 2003, 26:111-117.
11. Maeda N., Osuga K., Mikami K., et al. Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma. Radiat Med 2008, 26:206-212.
12. Lewandowski R.J., Wang D., Gehl J., et al. A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring. J Vasc Interv Radiol 2007, 18:1249-1257.
13. The Thrombolysis in Myocardial Infarction (TIMI) trial (Phase I findings). N Engl J Med 1985, 312:932-936. TIMI Study Group.
14. Brown D.B., Cardella J.F., Sacks D., et al. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 2006, 17:225-232.
15. Raoul J.L. Natural history of hepatocellular carcinoma and current treatment options. Semin Nucl Med 2008, 38:S13-S18.
16. Cancer facts & figures 2008, American Cancer Society, American Cancer Society, Atlanta, 2008.
17. Di Bisceglie A.M. Epidemiology and clinical presentation of hepatocellular carcinoma. J Vasc Intervent Radiol 2002, 13:S169-S172.
18. Davis C.R. Interventional radiological treatment of hepatocellular carcinoma. Cancer Control 2010, 17:87-99.
19. Solomon B., Soulen M.C., Baum R.A., Haskal Z.J., Shlansky-Goldberg R.D., Cope C. Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population. J Vasc Interv Radiol 1999, 10:793-798.
20. Mellinger E., Skinker L., Sears D., Gardner D., Shult P. Safe handling of chemotherapy in the perioperative setting. AORN J 2010, 91:435-450.
21. Wiggins E., Ibrahim S.M., Lewandowski R.J., Sato K.T., Omary R.A., Salem R. Effect of chemotherapy on hepatic vasculature in patients undergoing Y-90 radioembolization for metastatic disease. J Vasc Interv Radiol 2008, 19:S48-S49.
22. Erinjeri J.P., Salhab H.M., Covey A.M., Getrajdman G.I., Brown K.T. Arterial patency after repeated hepatic artery bland particle embolization. J Vasc Interv Radiol 2010, 21:522-526.
23. Guo W.J., Li J., Chen Z., et al. Transient increased expression of VEGF and MMP-1 in a rat liver tumor model after hepatic arterial occlusion. Hepatogastroenterology 2004, 51:381-386.
24. Rhee T.K., Young J.Y., Larson A.C., et al. Effect of transcatheter arterial embolization on levels of hypoxia inducible factor-1 alpha in rabbit VX2 liver tumors. J Vasc Interv Radiol 2007, 18:639-645.
25. Malagari K., Pomoni M., Kelekis A., et al. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Intervent Radiol 2010, 33:541-551.